In terms of global cognition, these patients showed significantly greater deterioration domains compared to those with GRN and MAPT mutations, as evidenced by lower scores on the MMSE, CDR-FTD-Sum of Boxes, and the FRS. This evidence concerns the gene GRN and frontotemporal dementia.